Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Jun;73(12):1556–1559. doi: 10.1038/bjc.1996.293

Growth rate of lung metastases and S-phase fraction as determined by flow cytometry from the primary tumour in 25 patients with bone or soft-tissue sarcomas.

C Blomqvist 1, R Huuhtanen 1, Y Pan 1, T Wiklund 1, M Tarkkanen 1, M Virolainen 1, B Tribukait 1
PMCID: PMC2074548  PMID: 8664129

Abstract

A significant correlation (r = -0.48) was found between the logarithm of the S-phase fraction of the primary tumour (SPF) and the logarithm of the doubling time of lung metastases (T2). The estimated median cell loss factor was 88% (range 35-99%).

Full text

PDF
1556

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Begg A. C., Hofland I., Moonen L., Bartelink H., Schraub S., Bontemps P., Le Fur R., Van Den Bogaert W., Caspers R., Van Glabbeke M. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int J Radiat Oncol Biol Phys. 1990 Dec;19(6):1449–1453. doi: 10.1016/0360-3016(90)90357-p. [DOI] [PubMed] [Google Scholar]
  2. Begg A. C., Moonen L., Hofland I., Dessing M., Bartelink H. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations. Radiother Oncol. 1988 Apr;11(4):337–347. doi: 10.1016/0167-8140(88)90205-8. [DOI] [PubMed] [Google Scholar]
  3. Blomqvist C., Wiklund T., Tarkkanen M., Elomaa I., Virolainen M. Measurement of growth rate of lung metastases in 21 patients with bone or soft-tissue sarcoma. Br J Cancer. 1993 Aug;68(2):414–417. doi: 10.1038/bjc.1993.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Charbit A., Malaise E. P., Tubiana M. Relation between the pathological nature and the growth rate of human tumors. Eur J Cancer. 1971 Aug;7(4):307–315. doi: 10.1016/0014-2964(71)90073-9. [DOI] [PubMed] [Google Scholar]
  5. Feichter G. E., Kaufmann M., Müller A., Haag D., Eckhardt R., Goerttler K. DNA index and cell cycle analysis of primary breast cancer and synchronous axillary lymph node metastases. Breast Cancer Res Treat. 1989 Jan;13(1):17–22. doi: 10.1007/BF01806546. [DOI] [PubMed] [Google Scholar]
  6. Forster G., Cooke T. G., Cooke L. D., Stanton P. D., Bowie G., Stell P. M. Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry. Br J Cancer. 1992 May;65(5):698–702. doi: 10.1038/bjc.1992.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hall P. A., Levison D. A. Review: assessment of cell proliferation in histological material. J Clin Pathol. 1990 Mar;43(3):184–192. doi: 10.1136/jcp.43.3.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Heiden T., Strang P., Stendahl U., Tribukait B. The reproducibility of flow cytometric analyses in human tumors. Methodological aspects. Anticancer Res. 1990 Jan-Feb;10(1):49–54. [PubMed] [Google Scholar]
  9. Heiden T., Wang N., Tribukait B. An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry. 1991;12(7):614–621. doi: 10.1002/cyto.990120705. [DOI] [PubMed] [Google Scholar]
  10. Joseph W. L., Morton D. L., Adkins P. C. Prognostic significance of tumor doubling time in evaluating operability in pulmonary metastatic disease. J Thorac Cardiovasc Surg. 1971 Jan;61(1):23–32. [PubMed] [Google Scholar]
  11. Kaern J., Tropé C. G., Kristensen G. B., Pettersen E. O. Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma. Cancer. 1994 Apr 1;73(7):1870–1877. doi: 10.1002/1097-0142(19940401)73:7<1870::aid-cncr2820730716>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  12. Kallioniemi O. P. Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry. 1988 Mar;9(2):164–169. doi: 10.1002/cyto.990090211. [DOI] [PubMed] [Google Scholar]
  13. Malaise E. P., Chavaudra N., Tubiana M. The relationship between growth rate, labelling index and histological type of human solid tumours. Eur J Cancer. 1973 Apr;9(4):305–312. doi: 10.1016/0014-2964(73)90099-6. [DOI] [PubMed] [Google Scholar]
  14. Mattson K., Holsti L. R. Prognostic value of doubling time in lung cancer. Strahlentherapie. 1980 Sep;156(9):632–636. [PubMed] [Google Scholar]
  15. Raza A., Preisler H. D., Day R., Yasin Z., White M., Lykins J., Kukla C., Barcos M., Bennett J., Browman G. Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a leukemia intergroup study. Blood. 1990 Dec 1;76(11):2191–2197. [PubMed] [Google Scholar]
  16. Rew D. A., Campbell I. D., Taylor I., Wilson G. D. Proliferation indices of invasive breast carcinomas after in vivo 5-bromo-2'-deoxyuridine labelling: a flow cytometric study of 75 tumours. Br J Surg. 1992 Apr;79(4):335–339. doi: 10.1002/bjs.1800790418. [DOI] [PubMed] [Google Scholar]
  17. Rew D. A., Wilson G. D., Taylor I., Weaver P. C. Proliferation characteristics of human colorectal carcinomas measured in vivo. Br J Surg. 1991 Jan;78(1):60–66. doi: 10.1002/bjs.1800780120. [DOI] [PubMed] [Google Scholar]
  18. Riccardi A., Danova M., Wilson G., Ucci G., Dörmer P., Mazzini G., Brugnatelli S., Girino M., McNally N. J., Ascari E. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry. Cancer Res. 1988 Nov 1;48(21):6238–6245. [PubMed] [Google Scholar]
  19. SPRATT J. S., Jr, SPRATT T. L. RATES OF GROWTH OF PULMONARY METASTASES AND HOST SURVIVAL. Ann Surg. 1964 Feb;159:161–171. doi: 10.1097/00000658-196402000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sakuma J. Cell kinetics of human squamous cell carcinomas in the oral cavity. Bull Tokyo Med Dent Univ. 1980 Mar;27(1):43–54. [PubMed] [Google Scholar]
  21. Silvestrini R., Sanfilippo O., Tedesco G. Kinetics of human mammary carcinomas and their correlation with the cancer and the host characteristics. Cancer. 1974 Oct;34(4):1252–1258. doi: 10.1002/1097-0142(197410)34:4<1252::aid-cncr2820340435>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  22. Steel G. G. Cell loss as a factor in the growth rate of human tumours. Eur J Cancer. 1967 Nov;3(4):381–387. doi: 10.1016/0014-2964(67)90022-9. [DOI] [PubMed] [Google Scholar]
  23. Wilson G. D., McNally N. J., Dische S., Saunders M. I., Des Rochers C., Lewis A. A., Bennett M. H. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer. 1988 Oct;58(4):423–431. doi: 10.1038/bjc.1988.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wu J. T., Wilson L. W. Progesterone receptor: stability studies and correlation between steroid binding assay and enzyme immunoassay. Clin Chem. 1988 Oct;34(10):1987–1991. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES